Platforma Badań Genetycznychsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-08-27
Share capital
7 950,00 PLN
Registered address
Aleja Prymasa Tysiąclecia 79A, 01-242 Warszawa, Poland
Website
zdrowegeny.plWebsite active
Phone
Social media

Financials

The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue
This companyUSD 28.56kMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD -32.62kMedianUSD -1.50kAverageUSD -84.98k
Operating costs
This companyUSD 61.18kMedianUSD 56.25kAverageUSD 2.29m
Assets
This companyUSD 241.85kMedianUSD 116.77kAverageUSD 2.72m

Bank accounts

Was a VAT taxpayer from 2015-08-06 to 2024-11-30. Removed from VAT register

Reason for removal: Art. 96 ust. 6-8

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant datePurposeGross amountGranting body
Jun 18, 2020
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282Prezydent Miasta Stołecznego Warszawy

Tenders

No recorded participation in tenders.

Authorized Representatives

Marek Kubicki — Management Board Member & President of the Management Board & Vice President of the Management Board
Przemysław Kulas — Vice President of the Management Board & President of the Management Board

Manner of representation

Each member of the company's management board is authorized to represent the company independently, in particular to make declarations of will concerning pecuniary and non-pecuniary rights and obligations, sign documents on behalf of the company and incur obligations.

Ownership

OwnerSharesShare valueStake
159$2,147.49100%

Beneficial owners

PersonRights
Marek Kubicki (48)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Przemysław Kulas (48)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

NameRevenueWebsite
Explorna Therapeuticssp. z o.o.$304,662.00explorna.com
Frontline BiosciencesS.A.$219,186.29frontlinebiosciences.com
AI Corelabsp. z o.o.$128,365.55aicorelab.com
ModicaP.S.A.$103,400.72modica.bio
WPD Pharmaceuticalssp. z o.o.$90,822.78wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.$87,561.70wpdpharmaceuticals.pl
Stenocoatsp. z o.o.$36,665.21stenocoat.com
Bioselsp. z o.o.$19,100.32selol.pl
Omnisepticasp. z o.o.$3,475.29omniseptica.com
Wavex Energysp. z o.o.$142.33wavexenergy.com

Change history

DateEvent
2018-04-27Address change (Rondo Organizacji Narodów Zjednoczonych 1, 00-124, Warszawa → Aleja Prymasa Tysiąclecia 79a, 01-242, Warszawa)
2015-08-27Entered in the register

FAQ

Last updated: 2026-02-17